LY-329722
N/A
Report date: 2023/05/22 10:17:35
Base Information
Drug NameLY-329722
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And CompanyShionogi & Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyShionogi & Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A